INBX
Inhibrx Biosciences, Inc.
100.40$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.01 | 0.01 | 0.03 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | – | – | |
| 0.00 | 0.02 | -0.01 | 0.01 | -0.05 | -0.04 | -0.04 | 0.04 | -0.04 | -0.04 | -0.03 | – | – | |
| 0.81 | 1.51 | 1.17 | 4.57 | 2.47 | 2.31 | 2.38 | 1.44 | 1.84 | 1.64 | 1.58 | 1.53 | 6.54 | |
| 0.17 | 0.14 | 0.18 | 6.31 | 0.51 | 1.15 | 0.39 | 0.42 | 0.34 | 0.36 | 0.37 | 0.53 | 1.58 | |
| 0.97 | 1.66 | 1.35 | 10.87 | 2.98 | 3.41 | 2.73 | 1.81 | 2.15 | 1.96 | 1.95 | 2.05 | 8.05 | |
| -0.97 | -1.63 | -1.35 | -10.87 | -3.03 | -3.45 | -2.77 | -1.77 | -2.18 | -2.00 | -1.98 | -2.05 | -8.16 | |
| 0.17 | 0.15 | 0.15 | 0.36 | 0.00 | 0.00 | 0.17 | 0.20 | 0.21 | 0.21 | 0.23 | 0.36 | 0.99 | |
| -1.10 | -1.73 | -1.44 | 125.48 | -2.84 | -3.31 | -2.80 | -1.85 | -2.28 | -2.12 | -2.15 | -2.34 | -8.82 | |
| 0.00 | 0.00 | 0.01 | 0.00 | – | – | – | 0.00 | – | – | – | 0.00 | – | |
| -1.10 | -1.73 | -1.44 | 125.48 | -2.84 | -3.31 | -2.80 | -1.85 | -2.28 | -2.12 | -2.15 | -2.34 | -8.82 | |
| -0.92 | -1.63 | -1.29 | 125.84 | -2.79 | -3.26 | -2.58 | -1.61 | -2.03 | -1.88 | -1.89 | -1.95 | -7.69 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.